As the pharmaceutical industry strives to extract meaningful insight, value and outcomes from their data analytics, pharma and biotech are experiencing a significant movement towards real-world evidence to power the advanced decision-making to optimize patient-centric
approaches.
This evolution has led to a fresh focus for the 4th Annual Advanced Pharma Analytics Summit (formerly know as Big Data in Pharma). Join the industry to learn about the successful application of advanced data analytics tools, including big data and predictive analytics, to progress products in the late stages of their life cycle. This year鈥檚 summit will also highlight the significant opportunities present within real-world evidence to compliment clinical trial data and to drive forward regulatory approval and post-approval evidence.
The 4th APA Summit 2016 will showcase the latest case studies from the likes of Genentech, Pfizer, Novartis and the FDA that demonstrate value and tangible ROI derived from effective data sourcing, standardization, integration, infrastructure, real-world evidence and advanced analytics. Discover the right technology, tools and customized analytics capabilities you need to make improved data-driven decisions to optimize health economics, market access, pricing and reimbursement strategies.
Join the Advanced Pharma Analytics community to fully realize and extract the right value and insight you need from your data and real-world evidence.
approaches.
This evolution has led to a fresh focus for the 4th Annual Advanced Pharma Analytics Summit (formerly know as Big Data in Pharma). Join the industry to learn about the successful application of advanced data analytics tools, including big data and predictive analytics, to progress products in the late stages of their life cycle. This year鈥檚 summit will also highlight the significant opportunities present within real-world evidence to compliment clinical trial data and to drive forward regulatory approval and post-approval evidence.
The 4th APA Summit 2016 will showcase the latest case studies from the likes of Genentech, Pfizer, Novartis and the FDA that demonstrate value and tangible ROI derived from effective data sourcing, standardization, integration, infrastructure, real-world evidence and advanced analytics. Discover the right technology, tools and customized analytics capabilities you need to make improved data-driven decisions to optimize health economics, market access, pricing and reimbursement strategies.
Join the Advanced Pharma Analytics community to fully realize and extract the right value and insight you need from your data and real-world evidence.
